Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023
STAMFORD, Conn., July 24, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment...
STAMFORD, Conn., July 24, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment...
SAN FRANCISCO, July 24, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its second quarter 2023 financial results...
Common stock and warrants of combined company will be listed on the New York Stock Exchange American under the symbols...
FLOQSwab-formatted QAPs Supporting Fourplex PCR Tests for Bacterial STIsMISSISSAUGA, Ontario, July 24, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX:...
Linda Burkly Editas Medicine today announced the appointment of Linda C. Burkly, Ph.D., as the Company’s Executive Vice President and...
New Findings Support Development of Racemic Tianeptine and (S)-Tianeptine (Estianeptine) as First-in-Class Oral Therapies in Alzheimer’s Disease and Other Psychiatric...
SUNNYVALE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. , a developer of cellular and cell-derived therapeutics for the treatment...
Term loan facility would provide for up to $125M in non-dilutive capital; $50M immediately available to Company following close of...
Tuebingen, Germany and Houston, TX, July 24, 2023 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in...
Replay and MD Anderson announce FDA clearance of IND application for first-in-class T-Cell Receptor Natural Killer (TCR-NK) cell therapy for...
Despite the availability of antibiotics, the death rate from pneumonia in the U.S. has seen little improvement in the past...
MAINZ, Germany, July 24, 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial...
Company to hold investor conference call on Monday, July 31, 2023 at 1:30 p.m. PT / 4:30 p.m. ETBRISBANE, Calif.,...
Tinlarebant (a/k/a LBS-008) is Belite Bio’s orally administered tablet intended to slow disease progression in patients with Stargardt Disease (STGD1)...
Continued calls for WHO resolution on self-careNYON, SWITZERLAND / ACCESSWIRE / July 24, 2023 / International Self-Care month 2023 opened...
Phase 3 study failed to meet one of the success criteria of the primary objectiveRSV program to be discontinuedCOPENHAGEN, Denmark,...
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Small Cell Lung CancerORLANDO, FL / ACCESSWIRE...
MEDELLÍN, COLOMBIA, ANTIOQUIA / ACCESSWIRE / July 22, 2023 / Situated in Medellin's prestigious "El Poblado," VeneersColombia.com stands out as...
CHICAGO, IL / ACCESSWIRE / July 21, 2023 / Cosmos Health Inc. (the "Company") (Nasdaq:COSM), a global healthcare group with...
SOUTHLAKE, TX / ACCESSWIRE / July 21, 2023 / Allied OMS - the country's only doctor-owned, doctor-led, and doctor-governed management...